Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis

NCT03148756 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped due to business reasons.

Conditions

Endocarditis
Bacteremia

Interventions

DRUG: Dalbavancin
DRUG: Standard of Care

Sponsor

AbbVie